| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Monte Rosa Therapeutics, Inc.'s insiders have reduced their positions by a net 13 shares worth roughly $137. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale. Classified under Biotechnology (Health Care sector), GLUE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.69M | - | - | |
| CEO | 585.0K | $13.56M | - | |
| Other | 67.8K | $1.58M | - | |
| COO | 62.4K | $248.2K | - | |
| Other | 60.6K | $1.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2021 | Sonsini Peter W. | 10% Owner | Buy | 1,050,000 | $19.00 | $19,950,000.00 | +15.8% | +28.8% | -49.9% | |
| Jun 28, 2021 | Walker Paul Edward47 | 10% Owner | Buy | 1,050,000 | $19.00 | $19,950,000.00 | +15.8% | +28.8% | -49.9% | |
| Jun 28, 2021 | Yang Rick | 10% Owner | Buy | 1,050,000 | $19.00 | $19,950,000.00 | +15.8% | +28.8% | -49.9% | |
| Jun 28, 2021 | Cormorant Asset Management, LP49 | Former 10% Owner | Buy | 600,000 | $19.00 | $11,400,000.00 | +23.1% | +28.8% | -49.9% |